Biotechnology research and development laboratories or services in health sciences (except nanobiotechnology research and development) · Pennsylvania
DM Clinical Research Philadelphia
Philadelphia, PA · ~27 workers · 2 years of OSHA Injury Tracking Application data.
- C
- Average Safety Record
- 0.0
- Avg TCR
- 0.5
- Industry avg
- 0
- Fatalities
The verdict
DM Clinical Research Philadelphia runs at 0% of its industry's injury rate - about level with the typical Biotechnology research and development laboratories or services in health sciences (except nanobiotechnology research and development) workplace, earning a grade C.
- C
- Average Safety Record
- 0.0
- avg TCR · per 100 workers
- 0.5
- industry benchmark (BLS)
- 0
- recordable injuries tracked
Grade compares DM Clinical Research Philadelphia's OSHA Total Case Rate of 0.0 to the Biotechnology research and development laboratories or services in health sciences (except nanobiotechnology research and development) BLS benchmark of 0.5 (0% of benchmark) across 2 years of Form 300A filings (2016–2024). <a href="/methodology">See methodology</a> for reporting-limitation caveats.
Injury rate over time
DM Clinical Research Philadelphia's yearly Total Case Rate, against the 0.5 industry benchmark.
Where DM Clinical Research Philadelphia falls in its industry
41 Biotechnology research and dev establishmentsSafer than 51% of graded establishments in this industry, whose median TCR is 0.1.
Trend analysis for DM Clinical Research Philadelphia
Between 2023 and 2024, DM Clinical Research Philadelphia's Total Case Rate held roughly steady from 0.0 to 0.0 recordable injuries per 100 full-time workers, a 0% change across 1 year of OSHA reporting.
The safest year on record was 2023, at a TCR of 0.0, while 2023 saw the highest rate, at 0.0, a spread of 0.0 points between the best and worst reporting years. That's a comparatively narrow spread, suggesting a fairly consistent safety record across the 2 years with a usable rate on file, rather than one outlier year skewing the multi-year average.
Summed across those 2 reporting years, DM Clinical Research Philadelphia recorded 0 total injuries and illnesses, with no fatalities reported in any of those years. Readers comparing establishments should weigh the 2-year trend above alongside establishment size, since a larger workforce naturally accumulates more raw incidents even at a lower per-100-worker rate.
Verify This Employer with OSHA
The 0 injuries shown on this page for DM Clinical Research Philadelphia are sourced from its own 2 years of mandatory OSHA Form 300A summaries. Cross-check the underlying establishment record directly against the federal source, name, NAICS classification, recordable case totals, and inspection history are all searchable on OSHA's Establishment-Specific Injury and Illness Data system.
Verify on OSHA Establishment SearchSource: U.S. Department of Labor, OSHA Establishment-Specific Injury and Illness Data. NAICS 541714 - Biotechnology research and development laboratories or services in health sciences (except nanobiotechnology research and development).
DART Rate, Transparent Calculation (2024)
What is the DART rate formula?
DART (Days Away, Restricted, or Transferred) is computed by OSHA as incidents × 200,000 ÷ hours worked. The 200,000-hour denominator equals roughly 100 full-time workers, which lets establishments of very different sizes be compared directly.
0 DART incidents × 200,000 ÷ 66,560 hours worked = 0.00 DART
Methodology: 29 CFR 1904, OSHA Form 300A recordkeeping
Cross-Validating Context, Establishment vs Industry vs State
| Benchmark | TCR | Source |
|---|---|---|
| DM Clinical Research Philadelphia (this establishment) | 0.00 | OSHA ITA Form 300A, 2-year avg |
| Biotechnology research and development laboratories or services in the medical sciences (except nanobiotechnology research and development) industry avg | 0.50 | BLS IIF, NAICS 541714 |
| Pennsylvania state avg (all industries) | 5.06 | OSHA ITA, state-level rollup |
Industry benchmarks: Bureau of Labor Statistics, Injuries, Illnesses, and Fatalities (IIF) program
Reportable Incident Timeline
Year-by-year reportable incidents (recordable injuries + illnesses + fatalities) submitted by DM Clinical Research Philadelphia to OSHA's Injury Tracking Application. Each row anchors to OSHA's inspection records search where you can pull the underlying inspection case numbers and citations for that establishment-year.
- 2024: 0 reportable incidents · 0 injuries, 0 illnesses, 0 fatalities - OSHA inspection records (case numbers)
- 2023: 0 reportable incidents · 0 injuries, 0 illnesses, 0 fatalities - OSHA inspection records (case numbers)
Source: OSHA Inspection Information System (IMIS) - inspection case-number records
Year-by-Year Safety Data
| Year | TCR | DART | Injuries | Illnesses | Fatalities |
|---|---|---|---|---|---|
| 2024 | 0.0 | 0.0 | 0 | 0 | 0 |
| 2023 | 0.0 | 0.0 | 0 | 0 | 0 |
What this grade means for you
Use this grade as a relative read on DM Clinical Research Philadelphia's reported OSHA injury record, strong versus its Biotechnology research and development laboratories or services in health sciences (except nanobiotechnology research and development) peers, but not a guarantee about any single site today.
- At 0% of the Biotechnology research and development laboratories or services in health sciences (except nanobiotechnology research and development) benchmark, DM Clinical Research Philadelphia reports fewer injuries than typical peers, still worth asking how safety is managed day to day. Know your rights
- Judge this record against the wider Biotechnology research and development laboratories or services in health sciences (except nanobiotechnology research and development) sector, where injury rates vary widely, before comparing it in isolation. See the industry
- Grades reflect 2016–2024 filings; check the latest establishment record straight from OSHA, or look up a different employer. Look up another
Safety grades reflect employers' self-reported OSHA Form 300A filings from 2016 to 2024 and can lag current conditions. A grade is not a guarantee that any specific workplace is safe or unsafe today. See our methodology and disclaimer.
Frequently Asked Questions
What is DM Clinical Research Philadelphia's safety grade?
How many injuries has DM Clinical Research Philadelphia reported?
Similar Employers
Matched by safety record across the industry, by workforce size within Pennsylvania, and by nearby establishments in Philadelphia - a different peer set than the category browse links below.
Similar TCR (~0.0)
Similar size (~27 workers)
Read our methodology - how this data is sourced, computed, and verified.
Every figure and grade on PlainSafetyScore is computed directly from OSHA's published Injury Tracking Application data and BLS industry benchmarks, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these safety grades, or report a data error. Data current as of 2016-2024 OSHA ITA release.